Davis's Drug Guide
depemokimab
General
Pronunciation:
dep-e-mok-i-mab
Trade Name(s)
- Exdensur
Ther. Class.
Pharm. Class.
monoclonal antibodies
interleukin antagonists
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Depemokimab." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. www.drugguide.com/ddo/view/Davis-Drug-Guide/3580173/all/depemokimab.
Vallerand AHA, Sanoski CAC. Depemokimab. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580173/all/depemokimab. Accessed September 13, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Depemokimab. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580173/all/depemokimab
Vallerand AHA, Sanoski CAC. Depemokimab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 September 13]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580173/all/depemokimab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - depemokimab
ID - 3580173
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580173/all/depemokimab
PB - F.A. Davis Company
ET - 20
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -